AliveCor raises $30m to develop use of AI to profile heart health
US healthtech AliveCor has raised $30m in funding, in a round led by Omron Healthcare and the Mayo Clinic. The California-based company also launched Kardia Pro, an artificial intelligence platform used to create a personal heart profile for each patient and help in the early detection of atrial fibrillation. AliveCor will use the funds to expand the business and accelerate innovations in heart health in the US, where heart disease is the number one cause of death.

AliveCor, a provider of FDA-cleared mobile electrocardiogram (ECG) technology has raised $30 million in funding led by Omron Healthcare and Mayo Clinic. Additionally, the company has unveiled its new AI-Powered platform, Kardia Pro for doctors to monitors patients for the early detection of atrial fibrillation. AliveCor plans to utilize the latest round of funding to accelerate innovations in heart health and continue the rapid expansion of the business.

“Heart disease is the No. 1 cause of death in the United States, claiming more lives than all forms of cancer combined. To manage heart disease and stroke risk, leading cardiologists want to see more than just ECGs from their patients,” said Vic Gundotra, AliveCor CEO in a statement. “Kardia Pro tracks important measures of physiology like weight, activity and blood pressure, and, for the first time, AI technology is used to create a personal heart profile for each user, enabling user identification. The new platform enables doctors to be better doctors and patients to be more active participants in their own heart health, driving healthcare forward into the 21st century.”